Biogen Inc.’s new at-home Alzheimer’s drug will give the company an edge over rival Eli Lilly Co.’s competing therapy, its ...

Investing.com -- Biogen Inc. ’s new at-home Alzheimer’s drug will provide an advantage over Eli Lilly Co. ’s competing ...

Three years after the accelerated approval of its anti-amyloid Alzheimer’s therapy, Biogen—neck and neck in the market with ...

U.S. pharmaceutical company Eli Lilly is expected to disclose the top-line results (key findings from phase 3 clinical trials ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

Eli Lilly's research and development head said on Monday the company will have plenty of supply to launch its ...

If you want to invest in strong stocks that you can hold on to forever, it's important to consider not only what their ...

Lilly has launched six early-stage clinical programs, and 34 discovery programs with a focus on incretins, amylins, and novel targets.

Jan 12 () - Swiss drugmaker Novartis has signed a licensing deal worth nearly $1.7 billion with privately held SciNeuro ...

Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...

CNW/ - Eli Lilly Canada Inc. ("Lilly") announced today that Ontario leads the way as the first province to add Olumiant® for ...

AbbVie and Novartis strike billion-dollar pacts while attendees at the J.P. Morgan Healthcare Conference await that one big M ...